Bianca Rocca/LinkedIn
Jun 29, 2026, 13:18
Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn about a recent article by Valeria Caso et al, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
”Delighted to share this just-released opinion by leading international experts addressing the current and evolving debate on Factor XI as a pharmacological target.
I hope you enjoy the article, and I wish everyone a great week!”
Title: Current opinion: the OCEANIC trial journey: from failure to breakthrough?
Authors: Valeria Caso, Hugo ten Cate, Isabelle C van Gelder
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 19:49Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
-
Sep 25, 2026, 19:47Bryan Cotton: DOACs Versus Nothing When Stroke Risk Is Not Zero
-
Sep 25, 2026, 19:45Selin Yaman Seval: ITP Is More Than a Low Platelet Count
-
Sep 25, 2026, 19:44Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count
-
Sep 25, 2026, 19:42Mahitap Hossam: What the Platelet Count Cannot Show in ITP
-
Sep 25, 2026, 17:13Sam Tsimikas: Lp(a) and Oxidized Phospholipids Link Lipoprotein Biology to Platelet Activation
-
Sep 25, 2026, 16:56Cindy Neunert: The Future of Personalized ITP Care
-
Sep 25, 2026, 16:26Gemma Postil: AI Tools in Modern Health Research
-
Sep 25, 2026, 16:01Mostafa Hammam: When aPTT Correction Is Not the End